Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018099 (
gout
)
5,192
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Retinol-binding protein 4
(
RBP4
) is a novel adipocytokine. It was observed that retinoid intoxication was related to acute attacks of
gout
. Furthermore, animal study has shown that colchicine inhibits RBP secretion. The aim of this study was to explore the association between
RBP4
level and metabolic parameters especially uric acid in patients with type 2 diabetes mellitus. Serum
RBP4
level was measured by a commercial competitive enzyme-linked immunosorbent assay kit, and its correlation with clinical and metabolic parameters was analyzed. Data on 885 subjects were used in the analysis. Pearson correlations revealed that serum
RBP4
level correlated positively with age, waist circumference, waist-to-hip ratio, systolic blood pressure, total cholesterol, triglyceride, uric acid, creatinine, and urine albumin-to-creatinine ratio. Serum
RBP4
level correlated negatively with estimated glomerular filtration rate but did not correlate with body mass index, homeostasis model assessment, A(1C), or high-sensitivity C-reactive protein. Multiple linear regression analysis with serum
RBP4
level as the dependent variable revealed that total cholesterol, triglyceride, uric acid, and albumin-to-creatinine ratio correlated independently and positively with serum
RBP4
level and that estimated glomerular filtration rate correlated independently and negatively with serum
RBP4
level. In conclusion,
RBP4
level was independently associated with uric acid level.
...
PMID:Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus. 1970 97